Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Related Posts
De Minimis Tariff Exemption Has Ended. How Will It Affect Shoppers?
The end of the “de minimis” exemption — which allowed packages less than $800 to enter the U.S. tariff-free —…
Nestlé’s Chief Is in Turnaround Mode. He Drinks 8 Cups of Coffee a Day.
Philipp Navratil recently took over the 160-year-old Swiss food giant, charged with reviving growth and regaining trust after his predecessor…
Why This Country’s Stock Market Is Up 30% This Year
South Korea has zoomed upward in anticipation that a new president will pass shareholder-friendly reforms, making it the best-performing market…